Whether this is due to endothelial or adipocyte PlGF production was not fully established, but it suggests that in addition to increased risk of type II diabetes21 and CVD19,23–25, up-regulation of PlGF in insulin resistance/hyperglycaemia and the metabolic syndrome may also accelerate the development of obesity. Here, PGF is linked to obesity due to melanocortin 4 receptor deficiency.